Memory T cell inflation: Understanding cause and effect

Trends in Immunology

Volumn 33, Issue 2, 2012, Pages 84-90

  O'Hara, Geraldine A ^a   Welten, Suzanne P M ^b   Klenerman, Paul ^a   Arens, Ramon ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytomegalovirus; Memory cells; T cells; Viral infections

Indexed keywords

CD27 ANTIGEN; CD28 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 7 RECEPTOR; L SELECTIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANTIGEN PRESENTING CELL; ARTERIOSCLEROSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL POPULATION; CELL SURVIVAL; CYTOKINE RELEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; IMMUNOMODULATION; IMMUNOSTIMULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY T LYMPHOCYTE; NONHUMAN; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINIA VIRUS; VIRUS LOAD; VIRUS REACTIVATION;

ANIMALS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNOLOGIC MEMORY; PHENOTYPE; T-LYMPHOCYTES; VACCINATION;

EID: 84856548651     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2011.11.005     Document Type: Review

References (79)

1. Cannon M.J., et al. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev. Med. Virol. 2010, 20:202-213.
2. Halwani R., et al. Generation and maintenance of human memory cells during viral infection. Springer Semin. Immunopathol. 2006, 28:197-208.
3. Sylwester A.W., et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 2005, 202:673-685.
4. Komatsu H., et al. Population analysis of antiviral T cell responses using MHC class I-peptide tetramers. Clin. Exp. Immunol. 2003, 134:9-12.
5. Holtappels R., et al. Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J. Virol. 2000, 74:11495-11503.
6. Karrer U., et al. Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J. Immunol. 2003, 170:2022-2029.
7. Munks M.W., et al. Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J. Immunol. 2006, 177:450-458.
8. Sierro S., et al. Evolution of diverse antiviral CD8+ T cell populations after murine cytomegalovirus infection. Eur. J. Immunol. 2005, 35:1113-1123.
9. Snyder C.M., et al. Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 2008, 29:650-659.
10. Gamadia L.E., et al. The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J. Immunol. 2004, 172:6107-6114.
11. Cicin-Sain L., et al. Cytomegalovirus-specific T cell immunity is maintained in immunosenescent rhesus macaques. J. Immunol. 2011, 187:1722-1732.
12. Waller E.C., et al. Dynamics of T cell memory in human cytomegalovirus infection. Med. Microbiol. Immunol. 2008, 197:83-96.
13. Ouyang Q., et al. Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J. Clin. Immunol. 2003, 23:247-257.
14. Arens R., et al. Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response. J. Immunol. 2008, 180:6472-6476.
15. Day C.L., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354.
16. Hertoghs K.M., et al. Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. J. Clin. Invest. 2010, 120:4077-4090.
17. Lang A., et al. Inflation and long-term maintenance of CD8 T cells responding to a latent herpesvirus depend upon establishment of latency and presence of viral antigens. J. Immunol. 2009, 183:8077-8087.
18. Klenerman P., Hill A. T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 2005, 6:873-879.
19. Munks M.W., et al. Genome-wide analysis reveals a highly diverse CD8 T cell response to murine cytomegalovirus. J. Immunol. 2006, 176:3760-3766.
20. Snyder C.M., et al. Sustained CD8+ T cell memory inflation after infection with a single-cycle cytomegalovirus. PLoS Pathog. 2011, 7:e1002295.
21. Hutchinson S., et al. A dominant role for the immunoproteasome in CD8+ T cell responses to murine cytomegalovirus. PLoS ONE 2011, 6:e14646.
22. Campbell A.E., et al. The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med. Microbiol. Immunol. 2008, 197:205-213.
23. Krmpotic A., et al. Pathogenesis of murine cytomegalovirus infection. Microbes Infect. 2003, 5:1263-1277.
24. Loewendorf A.I., et al. Dissecting the requirements for maintenance of the CMV-specific memory T-cell pool. Viral Immunol. 2011, 24:351-355.
25. Grzimek N.K., et al. Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs. J. Virol. 2001, 75:2692-2705.
26. Kurz S.K., et al. Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J. Virol. 1999, 73:482-494.
27. Simon C.O., et al. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation. J. Virol. 2006, 80:10436-10456.
28. Munks M.W., et al. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J. Immunol. 2007, 178:7235-7241.
29. Pinto A.K., et al. Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. J. Immunol. 2006, 177:3225-3234.
30. Snyder C.M., et al. Cross-presentation of a spread-defective MCMV is sufficient to prime the majority of virus-specific CD8+ T cells. PLoS ONE 2010, 5:e9681.
31. Torti N., et al. Batf3 transcription factor-dependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation. Eur. J. Immunol. 2011, 41:2612-2618.
32. Asano K., et al. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 2011, 34:85-95.
33. Seckert C.K., et al. Antigen-presenting cells of hematopoietic origin prime cytomegalovirus-specific CD8 T cells but are not sufficient for driving memory inflation during viral latency. J. Gen. Virol. 2011, 92:1994-2005.
34. Torti N., et al. Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection. PLoS Pathog. 2011, 7:e1002313.
35. Wakim L.M., Bevan M.J. Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection. Nature 2011, 471:629-632.
36. Arens R., Schoenberger S.P. Plasticity in programming of effector and memory CD8 T-cell formation. Immunol. Rev. 2010, 235:190-205.
37. Arens R., et al. Differential B7-CD28 costimulatory requirements for stable and inflationary mouse cytomegalovirus-specific memory CD8 T cell populations. J. Immunol. 2011, 186:3874-3881.
38. Humphreys I.R., et al. OX40 costimulation promotes persistence of cytomegalovirus-specific CD8 T cells: a CD4-dependent mechanism. J. Immunol. 2007, 179:2195-2202.
39. Humphreys I.R., et al. Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8+ T cells. Eur. J. Immunol. 2010, 40:2762-2768.
40. Bachmann M.F., et al. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections. Eur. J. Immunol. 2007, 37:1502-1512.
41. Feau S., et al. Autocrine IL-2 is required for secondary population expansion of CD8+ memory T cells. Nat. Immunol. 2011, 12:908-913.
42. van Leeuwen E.M., et al. IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. Blood 2005, 106:2091-2098.
43. Jones M., et al. IL-10 restricts memory T cell inflation during cytomegalovirus infection. J. Immunol. 2010, 185:3583-3592.
44. Jonjic S., et al. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J. Exp. Med. 1989, 169:1199-1212.
45. Arens R., et al. B7-mediated costimulation of CD4 T cells constrains cytomegalovirus persistence. J. Virol. 2011, 85:390-396.
46. Walton S.M., et al. Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells. PLoS Pathog. 2011, 7:e1002214.
47. Snyder C.M., et al. CD4+ T cell help has an epitope-dependent impact on CD8+ T cell memory inflation during murine cytomegalovirus infection. J. Immunol. 2009, 183:3932-3941.
48. Walton S.M., et al. T-cell help permits memory CD8+ T-cell inflation during cytomegalovirus latency. Eur. J. Immunol. 2011, 41:2248-2259.
49. Kotton C.N. Management of cytomegalovirus infection in solid organ transplantation. Nat. Rev. Nephrol. 2010, 6:711-721.
50. Nigro G., Adler S.P. Cytomegalovirus infections during pregnancy. Curr. Opin. Obstet. Gynecol. 2011, 23:123-128.
51. Riddell S.R., Greenberg P.D. T cell therapy of human CMV and EBV infection in immunocompromised hosts. Rev. Med. Virol. 1997, 7:181-192.
52. Einsele H., et al. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. Blood 2002, 99:3916-3922.
53. Brestrich G., et al. Adoptive T-cell therapy of a lung transplanted patient with severe CMV disease and resistance to antiviral therapy. Am. J. Transplant. 2009, 9:1679-1684.
54. Polic B., et al. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J. Exp. Med. 1998, 188:1047-1054.
55. Karrer U., et al. Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J. Virol. 2004, 78:2255-2264.
56. Hansen S.G., et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 2009, 15:293-299.
57. Hansen S.G., et al. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 2011, 473:523-527.
58. Slavuljica I., et al. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J. Clin. Invest. 2010, 120:4532-4545.
59. Streblow D.N., et al. Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr. Top. Microbiol. Immunol. 2008, 325:397-415.
60. Roberts E.T., et al. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. Am. J. Epidemiol. 2010, 172:363-371.
61. Roberts-Thomson I.C., et al. Ageing, immune response, and mortality. Lancet 1974, 2:368-370.
62. Murasko D.M., et al. Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin. Exp. Immunol. 1987, 70:440-448.
63. Nilsson B.O., et al. Morbidity does not influence the T-cell immune risk phenotype in the elderly: findings in the Swedish NONA Immune Study using sample selection protocols. Mech. Ageing Dev. 2003, 124:469-476.
64. Wikby A., et al. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech. Ageing Dev. 1998, 102:187-198.
65. Olsson J., et al. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech. Ageing Dev. 2000, 121:187-201.
66. Chidrawar S., et al. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin. Exp. Immunol. 2009, 155:423-432.
67. Trzonkowski P., et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination-an impact of immunosenescence. Vaccine 2003, 21:3826-3836.
68. den Elzen W.P., et al. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. Vaccine 2011, 29:4869-4874.
69. Khan N., et al. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. J. Immunol. 2004, 173:7481-7489.
70. van Leeuwen E.M., et al. Differential usage of cellular niches by cytomegalovirus versus EBV- and influenza virus-specific CD8+ T cells. J. Immunol. 2006, 177:4998-5005.
71. Vezys V., et al. Memory CD8 T-cell compartment grows in size with immunological experience. Nature 2009, 457:196-199.
72. Lang A., Nikolich-Zugich J. Functional CD8 T cell memory responding to persistent latent infection is maintained for life. J. Immunol. 2011, 187:3759-3768.
73. Swanson P.A., et al. Cutting edge: shift in antigen dependence by an antiviral MHC class Ib-restricted CD8 T cell response during persistent viral infection. J. Immunol. 2009, 182:5198-5202.
74. Swanson P.A., et al. An MHC class Ib-restricted CD8 T cell response confers antiviral immunity. J. Exp. Med. 2008, 205:1647-1657.
75. Isa A., et al. Prolonged activation of virus-specific CD8+ T cells after acute B19 infection. PLoS Med. 2005, 2:e343.
76. Norbeck O., et al. Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans. J. Virol. 2005, 79:12117-12121.
77. Simmons R., et al. High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo. J. Infect. Dis. 2011, 203:1378-1387.
78. Wherry E.J. T cell exhaustion. Nat. Immunol. 2011, 12:492-499.
79. Barber D.L., et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687.